EuropaBio Welcomes Commission Decision to Approve Five GMOs
EuropaBio welcomes the Commission’s important decision regarding the approval of a number of agricultural biotechnology files.
“We feel encouraged by this decisive regulatory approach” commented Willy De Greef, EuropaBio’s Secretary General. “It offers the necessary predictability to industry and also to the general public regarding the development of a technology that has much to offer to Europeans as a whole”.
Amongst the decisions was the first approval of a GM crop for cultivation in Europe since 1998. “There are a further 17 products in the approval process for cultivation and 44 products awaiting authorization for food and feed as well as for import and processing in the EU” qualified De Greef “However, today’s approvals represent a step in the right direction and a return to science-based decision making. This is essential if European farmers are to be given the freedom to choose whether or not to cultivate innovative GM crops, and if consumers are to be given the possibility to choose safe and beneficial GM products”
Most read news
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
BASF and universities jointly develop new process - Improvement of bioavailability of active ingredients

Celsius® SSM Shipper | Refrigerated containers | Sartorius
BGU researchers identify a gene for nearsightedness
Nottinghamshire_Deaf_Society

Therapeutic drug renders cancer cell weapon harmless - Already approved drug could pave way to new pharmaceuticals

New tests identify very early changes in Alzheimer's disease before symptoms appear
List_of_Panaeolus_species

Targeted drug delivery with these nanoparticles can make medicines more effective
